Verrica Pharmaceuticals (VRCA) Earnings Date & Reports

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

VRCA is expected to report earnings to fall 22.22% to -34 cents per share on August 11

Verrica Pharmaceuticals VRCA Stock Earnings Reports

Q2'26

Est.

$-0.35

Q1'26

Missed

by $0.03

Q4'25

Missed

by $0.51

Q3'25

Beat

by $0.21

Q2'25

Beat

by $0.11

The last earnings report on May 12 showed earnings per share of -44 cents, missing the estimate of -41 cents. With 36.00K shares outstanding, the current market capitalization sits at 104.79M.

View a ticker or compare two or three

Compare

VRCA

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for VRCA